EW
HOLX

Evoke Wealth’s Hologic HOLX Stock Holding History

Evoke Wealth’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-81
Closed -$5K – 711
2022
Q3 		$5K Sell
81
-7
-8% -$485 ﹤0.01% 878
2022
Q2 		$6K Buy
88
+28
+47% +$2.08K ﹤0.01% 849
2022
Q1 		$5K Buy
60
+25
+71% +$1.8K ﹤0.01% 903
2021
Q4 		$3K Hold
35
– – ﹤0.01% 991
2021
Q3 		$2K Hold
35
– – ﹤0.01% 1012
2021
Q2 		$2K Sell
35
-78
-69% -$5.21K ﹤0.01% 1049
2021
Q1 		$8K Buy
113
+75
+197% +$5.69K ﹤0.01% 725
2020
Q4 		$3K Hold
38
– – ﹤0.01% 821
2020
Q3 		$3K Hold
38
– – ﹤0.01% 771
2020
Q2 		$2K Sell
38
-13
-25% -$638 ﹤0.01% 864
2020
Q1 		$1.79K Sell
51
-18
-26% -$857 ﹤0.01% 819
2019
Q4 		$3.6K Hold
69
– – ﹤0.01% 976
2019
Q3 		$3.48K Buy
+69
New +$3.4K ﹤0.01% 1097

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Evoke Wealth's HOLX Position: Q4 2022 in Review

Evoke Wealth sold out of Hologic (HOLX) in Q4 2022, closing a stake of 81 shares — an estimated $5K sold.

Evoke Wealth first reported a position in HOLX in Q3 2019 and held it in 13 quarters. The position peaked at $8K in Q1 2021. 697 funds tracked by Wall St. Rank hold HOLX as of Q4 2022.

  • Evoke Wealth reported no remaining Hologic position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 81 Hologic shares in Q4 2022, an estimated $5K.
  • Evoke Wealth first reported a position in Hologic in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Hologic position peaked at $8K in Q1 2021.
  • 697 funds tracked by Wall St. Rank held Hologic as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.